BeStock  
Stocks › Medical Devices › AORT

Artivion AORT

US equityMarket cap rank #3235Medical Devices
$18.16 −$0.37 (-2.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.16 0.00%
Open$18.52
Prev close$18.53
Day range$18.13 – $18.93
Volume642.1K
Market cap$886.02M
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±10.4%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+25.2%
Worst reaction-28.3%

Stock move on the day after each report

+4.3%2023/Q4+12.8%2024/Q1-1.9%2024/Q2-0.9%2024/Q3-8.2%2024/Q4+15.4%2025/Q1+25.2%2025/Q2-5.5%2025/Q3-10.0%2025/Q4-28.3%2026/Q1+2.1%2026/Q2-20.2%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q35 Nov 2026After Market±24.5%-20.21%Within range
2026/Q26 Aug 2026After Market±14.7%+2.07%Within range
2026/Q17 May 2026After Market±13.8%-28.26%Bigger than priced
2025/Q412 Feb 2026After Market±12.1%-9.96%Within range
2025/Q36 Nov 2025After Market±14.2%-5.54%Within range
2025/Q27 Aug 2025After Market±9.7%+25.23%Bigger than priced
2025/Q15 May 2025After Market±17.0%+15.36%Within range
2024/Q424 Feb 2025After Market±13.8%-8.22%Within range
2024/Q37 Nov 2024After Market±19.7%-0.93%Within range
2024/Q28 Aug 2024After Market±15.8%-1.90%Within range
2024/Q16 May 2024After Market±11.6%+12.81%Bigger than priced
2023/Q415 Feb 2024After Market±16.0%+4.27%Within range
2023/Q32 Nov 2023After Market–+9.88%–
2023/Q23 Aug 2023After Market–-1.61%–
2023/Q14 May 2023After Market±13.4%+13.78%Bigger than priced
2022/Q416 Feb 2023After Market±24.4%+5.76%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Medical devices$98.16M 79.3%
  • Preservation services$25.63M 20.7%

Latest reported quarter: Q3, ended Sep 2026

Revenue$123.79M+9.2% YoY
Operating profit$2.95M-67.4% YoY
Net profit-$7.93M-221.9% YoY
Diluted EPS-$0.16-223.1% YoY
Free cash flow-$17.57M-199.5% YoY
Operating cash flow-$4.56M

Revenue, last 8 quarters

$97.3MDec '24$99.0MMar '25$113.0MJun '25$113.4MSep '25$116.0MDec '25$116.3MMar '26$125.8MJun '26$123.8MSep '26

Net profit, last 8 quarters

$-16.5MDec '24$-505.0KMar '25$1.3MJun '25$6.5MSep '25$2.4MDec '25$1.4MMar '26$-13.5MJun '26$-7.9MSep '26

Profitability & balance sheet

Gross margin63.3%
Operating margin1.6%
Net margin-3.6%
Return on equity-4.0%
Return on assets-1.8%
Return on invested capital-0.3%
Current ratio4.42
Liabilities / assets57.2%
Cash & investments$48.40M
Total debt$401.08M
Net cash (debt)-$352.68M

Discussion

No comments yet — be the first to weigh in on AORT.

Sign in to join the discussion.

Scroll to Top